DANIELLE MCFARLAND: Open Payments
NPI 1285750042 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,677 in 14 payments from 13 companies in 2025. Trend: 2023 $1,658 · 2024 $1,001 · 2025 $1,677
Food & beverage: $1,677
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $250 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Luye Pharma (USA) Ltd. | 1 | $130 |
| Amgen Inc. | 1 | $129 |
| E.R. Squibb & Sons, L.L.C. | 1 | $129 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Grifols USA, LLC | 1 | $123 |
Products named: VRAYLAR, INVEGA SUSTENNA, REZDIFFRA, ERZOFRI EXTENDED-RELEASE, KRYSTEXXA, COBENFY, JARDIANCE, ENTYVIO.
Industry payments across NY — which companies pay providers there.
